Drag a card by its title · ⚙ to size, swap or remove

The company

Lipocine Inc.

LPCN · Nasdaq

Health CareBiotechnologyNot moving yet

LPCN stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 29 weeks. It is 41.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 29
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $979K
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 32 (-13)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months7

Sale orders, 12 months0

Buyers · sellers2 · 0

Who	Did	Shares	Traded
John W. HiguchiDirector	bought	15,970at $2.23	30 Sep 2026filed 1 Oct 2026
John W. HiguchiDirector	bought	9,037at $2.15	29 Sep 2026filed 1 Oct 2026
John W. HiguchiDirector	bought	12,561at $2.16	28 Sep 2026filed 30 Sep 2026
John W. HiguchiDirector	bought	40,000at $2.03	7 Apr 2026filed 7 Apr 2026
Mahesh V. PatelChief Executive Officer	bought	25,000at $2.03	6 Apr 2026filed 6 Apr 2026
John W. HiguchiDirector	bought	123,000at $2.05	6 Apr 2026filed 6 Apr 2026
Mahesh V. PatelChief Executive Officer	bought	25,000at $2.02	2 Apr 2026filed 2 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders32-13 on the quarter

New · exited0 · 13

Reported value$7.0M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Squadron Capital Management LLCadded · filed 14 Aug 2026	810,000$2.1M	+360,000+80.0%
Ikarian Capital, LLCunchanged · filed 14 Aug 2026	508,556$1.3M	00.0%
Eversept Partners, LPunchanged · filed 14 Aug 2026	294,989$755K	00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	230,823$591K	+30,155+15.0%
BOOTHBAY FUND MANAGEMENT, LLCunchanged · filed 14 Aug 2026	140,487$360K	00.0%
JANE STREET GROUP, LLCadded · filed 14 Aug 2026	95,227$244K	+75,200+375.5%
BlackRock, Inc.unchanged · filed 7 Aug 2026	89,272$229K	00.0%
TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026	84,887$217K	+51,137+151.5%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026	81,221$208K	+52,133+179.2%
Seven Fleet Capital Management LPreduced · filed 17 Aug 2026	78,842$202K	-46,100−36.9%